A cascade of high-profile drug recalls and evolving FDA and EMA guidance have pushed nitrosamine risk assessment from a late-stage afterthought to an early-development priority
By tracking how cells respond to hundreds of thousands of compounds, Soley Therapeutics aims to discover medicines for complex diseases where traditional target-based approaches often fall short.
As deep B cell depletion moves into autoimmune disease, antibody-directed allogeneic NK cell therapy may offer a different path to potency, scalability, and outpatient treatment.
Decades of genomic and clinical research were not conducted equally across populations. AI trained on that history inherits it, which raises a real question: will AI-discovered medicines work equally well for everyone?
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.